Top Markets
Coin of the day
Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276
Rangering i aksjer #509
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Aksjekurs
$7.88
Sist synkronisert: 2026-08-12
Markedsverdi
$50.25B
Endring (1 dag)
-1.11%
Endring (1 år)
-9.73%
Land
CN
Handel Jiangsu Hengrui Medicine Co., Ltd. (600276)

Kategori

Aksjeprishistorikk for Jiangsu Hengrui Medicine Co., Ltd. (600276)
Høyeste sluttskurs: $7.90 den 2026-08-01

Laveste sluttskurs: $0.04 den 2005-07-01
Aksjeprishistorikk for Jiangsu Hengrui Medicine Co., Ltd. fra 2005 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -3.56%
2025 33.70%
2024 2.96%
2023 15.17%
2022 -30.24%
2021 -37.82%
2020 50.21%
2019 73.88%
2018 25.89%
2017 85.51%
2016 3.95%
2015 100.95%
2014 12.39%
2013 42.52%
2012 4.92%
2011 -16.03%
2010 40.18%
2009 61.62%
2008 -8.70%
2007 153.91%
2006 239.46%
2005 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$171.67 -
DE
$166.06 27.73%
DE
$36.20 22.35%
JP
$228.90 41.12%
CH
$21.45 14.41%
IN